|
2017 |
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Blocking CRMP2 SUMOylation reverses neuropathic pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism. |
Nam Lee, Ph.D. |
|
2017 |
Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. |
Patrick T Ronaldson, PhD |
|
2017 |
Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy. |
Nam Lee, Ph.D. |
|
2017 |
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. |
John M. Streicher, PhD |
|
2017 |
Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain. |
John M. Streicher, PhD |
|
2017 |
Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. |
Yeon Sun Lee, Frank Porreca, PhD |
|
2017 |
Remote Ischemic Conditioning Preserves Cognition and Motor Coordination in a Mouse Model of Traumatic Brain Injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke. |
|
|
2017 |
Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers. |
John M. Streicher, PhD |
|
2017 |
Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice. |
John M. Streicher, PhD |
|
2017 |
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD |
|
2017 |
Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD |
|
2017 |
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. |
John M. Streicher, PhD |
|
2017 |
Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD |
|
2017 |
Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy. |
Nam Lee, Ph.D. |
|
2017 |
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides. |
Todd Vanderah, PhD |
|
2017 |
Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Long-lasting antinociceptive effects of green light in acute and chronic pain in rats. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, T. Philip Malan, PhD, MD, Amol Patwardhan, M.D., Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD |
|
2017 |
Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. |
Jeffrey J. Lochhead, PhD |
|
2017 |
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
